Molecular fluorescent probe could enable advanced genetic testing

Aug. 15, 2013
Researchers in Japan have developed a new molecular fluorescent probe for polymerase chain reaction (PCR) DNA amplification techniques and DNA analysis in hybridization experiments.

Researchers from the RIKEN Center for Life Science Technologies and the Preventive Medicine & Diagnosis Innovation Program (both in Wako, Japan), as well as K.K.DNAFORM (Yokohama City, Japan), have developed a new molecular fluorescent probe for polymerase chain reaction (PCR) DNA amplification techniques and DNA analysis in hybridization experiments. The technology, dubbed Eprobe, will enable development of new, advanced assays for DNA-based genetic testing and help to bring the benefits of genome-wide sequencing studies to patients in the clinic.

Related: Unraveling the basis of disease with NIR molecular probes

Eprobes are short DNA oligonucleotides labeled with two fluorescent dye moieties attached to the same nucleotide. During the DNA amplification reaction, the probes bind to the newly synthesized DNA fragments, emitting a strong fluorescence signal upon binding, which enables researchers to monitor the reaction in real time. In the study, the researchers used Eprobes for the detection of genetic variations in the human EGFR and KRAS tumor genes by combining real-time PCR with a hybridization technique. They show that Eprobes provide decisive advantages over commonly used hybridization probes because of their unique background signal reduction, enhanced DNA-binding affinity, and very low false-positives rate.

Use of Eprobe in real-time PCR; hybridization-dependent signal of a double-labeled nucleotide as used in Eprobes.

“Eprobe enables real-time PCR methods, which are gaining importance for medical diagnostics and many life science applications, because they can provide quantitative results and increased reliability as compared to standard PCR methods,” explains Kengo Usui, the leader of the Genetic Diagnosis Technology Unit at the RIKEN Center for Life Science Technologies.

Takeshi Hanami, first author of the paper, explains that the new technology will enable the development of advanced assay formats for simultaneous detection of multiple target genes, which could be useful in tumor diagnosis.

The work appears in the journal PLoS ONE; for more information, please visit http://dx.plos.org/10.1371/journal.pone.0070942.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Sponsored Recommendations

Hexapod 6-DOF Active Optical Alignment Micro-Robots - Enablers for Advanced Camera Manufacturing

Dec. 18, 2024
Optics and camera manufacturing benefits from the flexibility of 6-Axis hexapod active optical alignment robots and advanced motion control software

Laser Assisted Wafer Slicing with 3DOF Motion Stages

Dec. 18, 2024
Granite-based high-performance 3-DOF air bearing nanopositioning stages provide ultra-high accuracy and reliability in semiconductor & laser processing applications.

Free Space Optical Communication

Dec. 18, 2024
Fast Steering Mirrors (FSM) provide fine steering precision to support the Future of Laser Based Communication with LEO Satellites

White Paper: Improving Photonic Alignment

Dec. 18, 2024
Discover how PI's FMPA Photonic Alignment Technology revolutionized the photonics industry, enabling faster and more economical testing at the wafer level. By reducing alignment...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!